EUCTR2008-007969-23-IT进行中（未招募）1 期
A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone with or without Lenalidomide in Subjects with Castrate-Resistant Prostate Cancer (CRPC)
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,059
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Screening and recruitment was completed under protocol amendment 2
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 317
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 742
排除标准
- •Screening and recruitment was completed under protocol amendment 2
研究者
相似试验
进行中（未招募）
不适用
A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg QD and 90 mg QD) and an Active Comparator, Lansoprazole (30 mgQD) on Healing of Erosive EsophagitisEUCTR2005-001187-31-CZTAP Pharmaceutical Products Inc.1,950
进行中（未招募）
不适用
A Study to Test the Effect and Safety of Brodalumab Compared With Placebo and Ustekinumab and the Results of Changing Strength or Frequency of Brodalumab in People with Moderate to Severe Plaque Psoriasis: AMAGINE-3Moderate to severe plaque psoriasisMedDRA version: 14.1Level: PTClassification code 10037153Term: PsoriasisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2012-000667-24-LVAmgen Inc.1,800
进行中（未招募）
不适用
A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg QD and 90 mg QD) and an Active Comparator, Lansoprazole (30 mgQD) on Healing of Erosive EsophagitisEUCTR2005-001188-70-LVTAP Pharmaceutical Products Inc.1,950
进行中（未招募）
不适用
Phase III CDK in refractory CEUCTR2011-005186-20-HUMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.466
进行中（未招募）
1 期
A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults with Familial Chylomicronemia SyndromeFamilial Chylomicronemia SyndromeMedDRA version: 24.1Level: LLTClassification code 10085051Term: Familial chylomicronemia syndromeSystem Organ Class: 100000004850EUCTR2021-003680-10-IEArrowhead Pharmaceuticals, Inc.60